Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Current status of health systems financing and oversight for end-stage kidney disease care: a cross-sectional global survey

E. Yeung, AK. Bello, A. Levin, M. Lunney, MA. Osman, F. Ye, G. Ashuntantang, E. Bellorin-Font, M. Benghanem Gharbi, S. Davison, M. Ghnaimat, P. Harden, V. Jha, K. Kalantar-Zadeh, P. Kerr, S. Klarenbach, C. Kovesdy, V. Luyckx, B. Neuen, D....

. 2021 ; 11 (7) : e047245. [pub] 20210709

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc21025377

OBJECTIVES: The Global Kidney Health Atlas (GKHA) is a multinational, cross-sectional survey designed to assess the current capacity for kidney care across all world regions. The 2017 GKHA involved 125 countries and identified significant gaps in oversight, funding and infrastructure to support care for patients with kidney disease, especially in lower-middle-income countries. Here, we report results from the survey for the second iteration of the GKHA conducted in 2018, which included specific questions about health financing and oversight of end-stage kidney disease (ESKD) care worldwide. SETTING: A cross-sectional global survey. PARTICIPANTS: Key stakeholders from 182 countries were invited to participate. Of those, stakeholders from 160 countries participated and were included. PRIMARY OUTCOMES: Primary outcomes included cost of kidney replacement therapy (KRT), funding for dialysis and transplantation, funding for conservative kidney management, extent of universal health coverage, out-of-pocket costs for KRT, within-country variability in ESKD care delivery and oversight systems for ESKD care. Outcomes were determined from a combination of desk research and input from key stakeholders in participating countries. RESULTS: 160 countries (covering 98% of the world's population) responded to the survey. Economic factors were identified as the top barrier to optimal ESKD care in 99 countries (64%). Full public funding for KRT was more common than for conservative kidney management (43% vs 28%). Among countries that provided at least some public coverage for KRT, 75% covered all citizens. Within-country variation in ESKD care delivery was reported in 40% of countries. Oversight of ESKD care was present in all high-income countries but was absent in 13% of low-income, 3% of lower-middle-income, and 10% of upper-middle-income countries. CONCLUSION: Significant gaps and variability exist in the public funding and oversight of ESKD care in many countries, particularly for those in low-income and lower-middle-income countries.

Bhumirajanagarindra Kidney Institute Bangkok Thailand

Centre for Kidney Disease Research The University of Queensland Saint Lucia Queensland Australia

Centre for Transplantation and Renal Research Westmead Institute for Medical Research Westmead New South Wales Australia

Department of Community Health Sciences University of Calgary Calgary Alberta Canada

Department of Infection Inflammation and Immunity University of Leicester Leicester UK

Department of Intensive Care Austin Health Heidelberg Victoria Australia

Department of Internal Disease and Nephrology North Western State Medical University named after 1 I Mechnikov Sankt Peterburg Russia

Department of Internal Medicine Saint Louis University Saint Louis Missouri USA

Department of Internal Medicine The Specialty Hospital Amman Jordan

Department of Medical Informatics Academic Medical Center University of Amsterdam Amsterdam Netherlands

Department of Medicine Cumming School of Medicine University of Calgary Calgary Alberta Canada

Department of Medicine King Chulalong Memorial Hospital Bangkok Thailand

Department of Medicine Monash University Clayton Victoria Australia

Department of Medicine University of Alberta Faculty of Medicine and Dentistry Edmonton Alberta Canada

Department of Medicine University of Hong Kong Hong Kong Hong Kong

Department of Nephrology Charles University Praha Czech Republic

Department of Nephrology Kidney Foundation Hospital and Research Institute Dhaka Bangladesh

Department of Nephrology Monash Medical Centre Clayton Clayton Victoria Australia

Department of Nephrology St Michael's Hospital Toronto Ontario Canada

Dialysis Unit CASMU IAMPP Montevideo Uruguay

Division of Nephrology and Hypertension University of California Irvine Medical Center Orange California USA

Division of Nephrology and Immunology University of Alberta Edmonton Alberta Canada

Division of Nephrology and Immunology University of Alberta Faculty of Medicine and Dentistry Edmonton Alberta Canada

Division of Nephrology Bezmialem Vakif Universitesi Istanbul Turkey

Division of Nephrology University of British Columbia Vancouver British Columbia Canada

Division of Nephrology University of Toronto Faculty of Medicine Toronto Ontario Canada

Faculty of Biology Medicine and Health The University of Manchester Manchester UK

Faculty of Medicine and Biomedical Sciences University of Yaounde 1 Faculty of Medicine and Biomedical Sciences Yaounde Cameroon

George Institute for Global Health New Dehli India

Hasheminejad Kidney Center Iran University of Medical Sciences Tehran Iran

Institute of Biomedical Ethics and the History of Medicine University of Zurich Institute of Biomedical Ethics History of Medicine Zurich Switzerland

Intensive Care Nephrology and Transplantation Department Assistance Publique Hopitaux de Paris Paris France

Kidney Research Center Chang Gung University College of Medicine Taoyuan Taiwan

Medicine University of Alberta Edmonton Alberta Canada

Medicine University of Cape Town Cape Town South Africa

Metro South Integrated Nephrology and Transplant Services Princess Alexandra Hospital Woolloongabba Queensland Australia

Monash Health Clayton Victoria Australia

Nephrology Development Clinical Center Tbilisi State Medical University Tbilisi Georgia

Nephrology Memphis VA Medical Center Memphis Tennessee USA

Oxford Kidney Unit Oxford University Hospitals NHS Trust Oxford UK

Population Health Sciences University of Bristol Bristol UK

Renal Division Peking University 1st Hospital Peking University Institute of Nephrology Beijing China

Salford Royal Hospitals NHS Trust Salford UK

The George Institute for Global Health Newtown New South Wales Australia

Urinary Tract Diseases Department University of Hassan 2 Casablanca Faculty of Science Ain Chock Casablanca Morocco

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21025377
003      
CZ-PrNML
005      
20211026133856.0
007      
ta
008      
211013s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/bmjopen-2020-047245 $2 doi
035    __
$a (PubMed)34244267
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Yeung, Emily $u Monash Health, Clayton, Victoria, Australia emily.yeung@monashhealth.org
245    10
$a Current status of health systems financing and oversight for end-stage kidney disease care: a cross-sectional global survey / $c E. Yeung, AK. Bello, A. Levin, M. Lunney, MA. Osman, F. Ye, G. Ashuntantang, E. Bellorin-Font, M. Benghanem Gharbi, S. Davison, M. Ghnaimat, P. Harden, V. Jha, K. Kalantar-Zadeh, P. Kerr, S. Klarenbach, C. Kovesdy, V. Luyckx, B. Neuen, D. O'Donoghue, S. Ossareh, J. Perl, H. Ur Rashid, E. Rondeau, E. See, S. Saad, L. Sola, I. Tchokhonelidze, V. Tesar, K. Tungsanga, R. Turan Kazancioglu, AY. Wang, N. Wiebe, CW. Yang, A. Zemchenkov, M. Zhao, KJ. Jager, F. Caskey, V. Perkovic, K. Jindal, IG. Okpechi, M. Tonelli, J. Feehally, DC. Harris, D. Johnson
520    9_
$a OBJECTIVES: The Global Kidney Health Atlas (GKHA) is a multinational, cross-sectional survey designed to assess the current capacity for kidney care across all world regions. The 2017 GKHA involved 125 countries and identified significant gaps in oversight, funding and infrastructure to support care for patients with kidney disease, especially in lower-middle-income countries. Here, we report results from the survey for the second iteration of the GKHA conducted in 2018, which included specific questions about health financing and oversight of end-stage kidney disease (ESKD) care worldwide. SETTING: A cross-sectional global survey. PARTICIPANTS: Key stakeholders from 182 countries were invited to participate. Of those, stakeholders from 160 countries participated and were included. PRIMARY OUTCOMES: Primary outcomes included cost of kidney replacement therapy (KRT), funding for dialysis and transplantation, funding for conservative kidney management, extent of universal health coverage, out-of-pocket costs for KRT, within-country variability in ESKD care delivery and oversight systems for ESKD care. Outcomes were determined from a combination of desk research and input from key stakeholders in participating countries. RESULTS: 160 countries (covering 98% of the world's population) responded to the survey. Economic factors were identified as the top barrier to optimal ESKD care in 99 countries (64%). Full public funding for KRT was more common than for conservative kidney management (43% vs 28%). Among countries that provided at least some public coverage for KRT, 75% covered all citizens. Within-country variation in ESKD care delivery was reported in 40% of countries. Oversight of ESKD care was present in all high-income countries but was absent in 13% of low-income, 3% of lower-middle-income, and 10% of upper-middle-income countries. CONCLUSION: Significant gaps and variability exist in the public funding and oversight of ESKD care in many countries, particularly for those in low-income and lower-middle-income countries.
650    _2
$a průřezové studie $7 D003430
650    _2
$a rozvojové země $7 D003906
650    _2
$a dostupnost zdravotnických služeb $7 D006297
650    _2
$a lidé $7 D006801
650    12
$a chronické selhání ledvin $x terapie $7 D007676
650    12
$a dialýza ledvin $7 D006435
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bello, A K $u Division of Nephrology and Immunology, University of Alberta, Edmonton, Alberta, Canada
700    1_
$a Levin, Adeera $u Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada
700    1_
$a Lunney, Meaghan $u Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada
700    1_
$a Osman, Mohamed A $u Medicine, University of Alberta, Edmonton, Alberta, Canada
700    1_
$a Ye, Feng $u Division of Nephrology and Immunology, University of Alberta, Edmonton, Alberta, Canada
700    1_
$a Ashuntantang, Gloria $u Faculty of Medicine and Biomedical Sciences, University of Yaounde I Faculty of Medicine and Biomedical Sciences, Yaounde, Cameroon
700    1_
$a Bellorin-Font, Ezequiel $u Department of Internal Medicine, Saint Louis University, Saint Louis, Missouri, USA
700    1_
$a Benghanem Gharbi, Mohammed $u Urinary Tract Diseases Department, University of Hassan II Casablanca Faculty of Science Ain Chock, Casablanca, Morocco
700    1_
$a Davison, Sara $u Division of Nephrology and Immunology, University of Alberta Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada
700    1_
$a Ghnaimat, Mohammad $u Department of Internal Medicine, The Specialty Hospital, Amman, Jordan
700    1_
$a Harden, Paul $u Oxford Kidney Unit, Oxford University Hospitals NHS Trust, Oxford, UK
700    1_
$a Jha, Vivekanand $u George Institute for Global Health, New Dehli, India
700    1_
$a Kalantar-Zadeh, Kamyar $u Division of Nephrology and Hypertension, University of California Irvine Medical Center, Orange, California, USA
700    1_
$a Kerr, Peter $u Department of Nephrology, Monash Medical Centre Clayton, Clayton, Victoria, Australia $u Department of Medicine, Monash University, Clayton, Victoria, Australia
700    1_
$a Klarenbach, Scott $u Medicine, University of Alberta, Edmonton, Alberta, Canada
700    1_
$a Kovesdy, Csaba $u Nephrology, Memphis VA Medical Center, Memphis, Tennessee, USA
700    1_
$a Luyckx, Valerie $u Institute of Biomedical Ethics and the History of Medicine, University of Zurich Institute of Biomedical Ethics History of Medicine, Zurich, Switzerland
700    1_
$a Neuen, Brendon $u The George Institute for Global Health, Newtown, New South Wales, Australia
700    1_
$a O'Donoghue, Donal $u Salford Royal Hospitals NHS Trust, Salford, UK $u Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK
700    1_
$a Ossareh, Shahrzad $u Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran
700    1_
$a Perl, Jeffrey $u Department of Nephrology, St Michael's Hospital, Toronto, Ontario, Canada $u Division of Nephrology, University of Toronto Faculty of Medicine, Toronto, Ontario, Canada
700    1_
$a Ur Rashid, Harun $u Department of Nephrology, Kidney Foundation Hospital and Research Institute, Dhaka, Bangladesh
700    1_
$a Rondeau, Eric $u Intensive Care Nephrology and Transplantation Department, Assistance Publique-Hopitaux de Paris, Paris, France
700    1_
$a See, Emily $u Department of Intensive Care, Austin Health, Heidelberg, Victoria, Australia
700    1_
$a Saad, Syed $u Division of Nephrology and Immunology, University of Alberta, Edmonton, Alberta, Canada
700    1_
$a Sola, Laura $u Dialysis Unit, CASMU-IAMPP, Montevideo, Uruguay
700    1_
$a Tchokhonelidze, Irma $u Nephrology Development Clinical Center, Tbilisi State Medical University, Tbilisi, Georgia
700    1_
$a Tesar, Vladimir $u Department of Nephrology, Charles University, Praha, Czech Republic
700    1_
$a Tungsanga, Kriang $u Department of Medicine, King Chulalong Memorial Hospital, Bangkok, Thailand $u Bhumirajanagarindra Kidney Institute, Bangkok, Thailand
700    1_
$a Turan Kazancioglu, Rumeyza $u Division of Nephrology, Bezmialem Vakif Universitesi, Istanbul, Turkey
700    1_
$a Wang, Angela Yee-Moon $u Department of Medicine, University of Hong Kong, Hong Kong, Hong Kong
700    1_
$a Wiebe, Natasha $u Department of Medicine, University of Alberta Faculty of Medicine and Dentistry, Edmonton, Alberta, Canada
700    1_
$a Yang, Chih-Wei $u Kidney Research Center, Chang Gung University College of Medicine, Taoyuan, Taiwan
700    1_
$a Zemchenkov, Alexander $u Department of Internal Disease and Nephrology, North-Western State Medical University named after I I Mechnikov, Sankt-Peterburg, Russia
700    1_
$a Zhao, Minhui $u Renal Division, Peking University First Hospital, Peking University Institute of Nephrology, Beijing, China
700    1_
$a Jager, Kitty J $u Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
700    1_
$a Caskey, Fergus $u Population Health Sciences, University of Bristol, Bristol, UK
700    1_
$a Perkovic, Vlado $u The George Institute for Global Health, Newtown, New South Wales, Australia
700    1_
$a Jindal, Kailash $u Medicine, University of Alberta, Edmonton, Alberta, Canada
700    1_
$a Okpechi, Ikechi G $u Medicine, University of Cape Town, Cape Town, South Africa
700    1_
$a Tonelli, Marcello $u Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
700    1_
$a Feehally, John $u Department of Infection, Inflammation and Immunity, University of Leicester, Leicester, UK
700    1_
$a Harris, David Ch $u Centre for Transplantation and Renal Research, Westmead Institute for Medical Research, Westmead, New South Wales, Australia
700    1_
$a Johnson, David $u Centre for Kidney Disease Research, The University of Queensland, Saint Lucia, Queensland, Australia $u Metro South Integrated Nephrology and Transplant Services (MINTS), Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
773    0_
$w MED00184484 $t BMJ open $x 2044-6055 $g Roč. 11, č. 7 (2021), s. e047245
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34244267 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20211013 $b ABA008
991    __
$a 20211026133902 $b ABA008
999    __
$a ok $b bmc $g 1714424 $s 1145884
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 11 $c 7 $d e047245 $e 20210709 $i 2044-6055 $m BMJ open $n BMJ Open $x MED00184484
LZP    __
$a Pubmed-20211013
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace